Literature DB >> 19656134

Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations.

Q Zhou1, J Yan, P Putheti, Y Wu, X Sun, V Toxavidis, J Tigges, N Kassam, K Enjyoji, S C Robson, T B Strom, W Gao.   

Abstract

Foxp3(+) regulatory T cells (Tregs) express both ectoenzymes CD39 and CD73, which in tandem hydrolyze pericellular ATP into adenosine, an immunoinhibitory molecule that contributes to Treg suppressive function. Using Foxp3GFP knockin mice, we noted that the mouse CD4(+)CD39(+) T-cell pool contains two roughly equal size Foxp3(+) and Foxp3(-) populations. While Foxp3(+)CD39(+) cells are CD73(bright) and are the bone fide Tregs, Foxp3(-)CD39(+) cells do not have suppressive activity and are CD44(+)CD62L(-)CD25(-)CD73(dim/-), exhibiting memory cell phenotype. Functionally, CD39 expression on memory and Treg cells confers protection against ATP-induced apoptosis. Compared with Foxp3(-)CD39(-) naïve T cells, Foxp3(-)CD39(+) cells freshly isolated from non-immunized mice express at rest significantly higher levels of mRNA for T-helper lineage-specific cytokines IFN-gamma (Th1), IL-4/IL-10 (Th2), IL-17A/F (Th17), as well as pro-inflammatory cytokines, and rapidly secrete these cytokines upon stimulation. Moreover, the presence of Foxp3(-)CD39(+) cells inhibits TGF-beta induction of Foxp3 in Foxp3(-)CD39(-) cells. Furthermore, when transferred in vivo, Foxp3(-)CD39(+) cells rejected MHC-mismatched skin allografts in a much faster tempo than Foxp3(-)CD39(-) cells. Thus, besides Tregs, CD39 is also expressed on pre-existing memory T cells of Th1-, Th2- and Th17-types with heightened alloreactivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656134      PMCID: PMC2930268          DOI: 10.1111/j.1600-6143.2009.02777.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Homeostatic proliferation is a barrier to transplantation tolerance.

Authors:  Zihao Wu; Steven J Bensinger; Jidong Zhang; Chuangqi Chen; Xueli Yuan; Xiaolun Huang; James F Markmann; Alireza Kassaee; Bruce R Rosengard; Wayne W Hancock; Mohamed H Sayegh; Laurence A Turka
Journal:  Nat Med       Date:  2003-11-30       Impact factor: 53.440

3.  High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors.

Authors:  Fred Aswad; Hiroki Kawamura; Gunther Dennert
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

Review 4.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

5.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

6.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.

Authors:  S Qin; J B Rottman; P Myers; N Kassam; M Weinblatt; M Loetscher; A E Koch; B Moser; C R Mackay
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

7.  Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

Authors:  K Enjyoji; J Sévigny; Y Lin; P S Frenette; P D Christie; J S Esch; M Imai; J M Edelberg; H Rayburn; M Lech; D L Beeler; E Csizmadia; D D Wagner; S C Robson; R D Rosenberg
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

8.  Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation.

Authors:  Jean Sévigny; Christian Sundberg; Norbert Braun; Olaf Guckelberger; Eva Csizmadia; Imrana Qawi; Masato Imai; Herbert Zimmermann; Simon C Robson
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

9.  Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages.

Authors:  Peter J Hanley; Boris Musset; Vijay Renigunta; Sven H Limberg; Alexander H Dalpke; Rainer Sus; Klaus M Heeg; Regina Preisig-Müller; Jürgen Daut
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-11       Impact factor: 11.205

10.  GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.

Authors:  Pierre-Yves Mantel; Harmjan Kuipers; Onur Boyman; Claudio Rhyner; Nadia Ouaked; Beate Rückert; Christian Karagiannidis; Bart N Lambrecht; Rudolf W Hendriks; Reto Crameri; Cezmi A Akdis; Kurt Blaser; Carsten B Schmidt-Weber
Journal:  PLoS Biol       Date:  2007-12       Impact factor: 8.029

View more
  40 in total

1.  Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.

Authors:  Patrick J Schuler; Malgorzata Harasymczuk; Bastian Schilling; Stephan Lang; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2011-04-13       Impact factor: 2.303

2.  Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis.

Authors:  Irina Kochetkova; Theresa Thornburg; Gayle Callis; David W Pascual
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

3.  Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.

Authors:  K M Dwyer; D Hanidziar; P Putheti; P A Hill; S Pommey; J L McRae; A Winterhalter; G Doherty; S Deaglio; M Koulmanda; W Gao; S C Robson; T B Strom
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

4.  Characteristic expression of MSX1, MSX2, TBX2 and ENTPD1 in dental pulp cells.

Authors:  Sakiko Fujii; Katsumi Fujimoto; Noriko Goto; Masami Kanawa; Takeshi Kawamoto; Haiou Pan; Petcharin Srivatanakul; Waralak Rakdang; Juthamas Pornprasitwech; Tania Saskianti; Ketut Suardita; Fusanori Nishimura; Yukio Kato
Journal:  Biomed Rep       Date:  2015-04-29

Review 5.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

6.  Tumor-infiltrating CD39+γδTregs are novel immunosuppressive T cells in human colorectal cancer.

Authors:  Guoming Hu; Pin Wu; Pu Cheng; Zhigang Zhang; Zhen Wang; Xiuyan Yu; Xuan Shao; Dang Wu; Jun Ye; Tao Zhang; Xiaochen Wang; Fuming Qiu; Jun Yan; Jian Huang
Journal:  Oncoimmunology       Date:  2017-01-06       Impact factor: 8.110

7.  High expression of CD39 in gastric cancer reduces patient outcome following radical resection.

Authors:  Xiao-Yan Cai; Xue-Fei Wang; Jun Li; Jiang-Nan Dong; Jiang-Qi Liu; Neng-Ping Li; Bei Yun; Rong-Long Xia; Jing Qin; Yi-Hong Sun
Journal:  Oncol Lett       Date:  2016-09-26       Impact factor: 2.967

8.  CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.

Authors:  Xiaofeng Sun; Yan Wu; Wenda Gao; Keiichi Enjyoji; Eva Csizmadia; Christa E Müller; Takashi Murakami; Simon C Robson
Journal:  Gastroenterology       Date:  2010-06-25       Impact factor: 22.682

Review 9.  Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers.

Authors:  M Segovia; S Russo; M R Girotti; G A Rabinovich; M Hill
Journal:  Clin Exp Immunol       Date:  2020-05       Impact factor: 4.330

10.  CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.

Authors:  Jan Schulte Am Esch; Simon C Robson; Moritz Schmelzle; Constanze Duhme; Wolfgang Junger; Steven D Salhanick; Yu Chen; Yan Wu; Vasilis Toxavidis; Eva Csizmadia; Lihui Han; Shu Bian; Günter Fürst; Martina Nowak; Seth J Karp; Wolfram T Knoefel
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.